Sequential follow-up clinic and ambulatory blood pressure evaluation in a low risk population of white-coat hypertensive patients and in normotensives

Blood Pressure Monitoring

Volumn 10, Issue 2, 2005, Pages 57-64

  Polónia, Jorge J ^a,b,d   Gama, Guilherme M ^b   Silva, José A ^a   Amaral, Cristina ^c   Martins, Luis R ^c   Bertoquini, Susana E ^c  

^a HOSPITAL PEDRO HISPANO   (Portugal)

^b University of Porto   (Portugal)

^c UNIVERSIDADE FERNANDO PESSOA   (Portugal)

^d HOSPITAL DE SÃO JOÃO   (Portugal)

Author keywords

24 h ambulatory BP monitoring; Longitudinal study; White coat hypertension

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIHYPERTENSIVE AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM ANTAGONIST; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT;

ADULT; ANGINA PECTORIS; ARTICLE; BLOOD PRESSURE MONITORING; BODY MASS; CARDIOVASCULAR RISK; CEREBROVASCULAR ACCIDENT; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DISEASE COURSE; FEMALE; FOLLOW UP; HEART LEFT VENTRICLE MASS; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL ASSESSMENT; METABOLIC PARAMETERS; OUTPATIENT DEPARTMENT; POPULATION; PRIORITY JOURNAL; PROSPECTIVE STUDY; RECORDING; SEQUENTIAL ANALYSIS; SUBARACHNOID HEMORRHAGE; SYSTOLIC BLOOD PRESSURE; WAKEFULNESS; WHITE COAT HYPERTENSION;

ADULT; BLOOD CELLS; BLOOD PRESSURE MONITORING, AMBULATORY; CIRCADIAN RHYTHM; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; PHYSICIANS' OFFICES; PROSPECTIVE STUDIES; RISK FACTORS;

EID: 17844409848     PISSN: 13595237     EISSN: None     Source Type: Journal    
DOI: 10.1097/00126097-200504000-00001     Document Type: Article

References (40)

1. Mancia G, Parati G. Clinical significance of 'white coat' hypertension [editorial; comment]. Hypertension 1990; 16:624-626.
2. Pickering TG. White coat hypertension: time for action. Circulation 1998; 98:1834-1836.
3. Verdecchia P, Schillaci G, Boldrini F, Zampi I, Porcellati C. Variability between current definitions of 'normal' ambulatory blood pressure. Implications in the assessment of white coat hypertension. Hypertension 1992; 20:555-562.
4. White WB, Schulman P, McCabe EJ, Dey HM. Average daily blood pressure, not office blood pressure, determines cardiac function in patients with hypertension. JAMA 1989; 261:873-877.
5. Pierdomenico SD, Lapenna D, Guglielmi MD, Antidormi T, Schiavone C, Cuccurullo F, et al. Target organ status and serum lipids in patients with white coat hypertension. Hypertension 1995; 26:801-807.
6. Cavallini MC, Roman MJ, Pickering TG, Schwartz JE, Pini R, Devereux RB. Is white coat hypertension associated with arterial disease or left ventricular hypertrophy? Hypertension 1995; 26:413-419.
7. Cuspidi C, Marabini M, Lonati L, Sampleri L, Comerio G, Pelizzoli S, et al. Cardiac and carotid structure in patients with established hypertension and white-coat hypertension. J Hypertens. 1995; 13:1707-1711.
8. Verdecchia P, Porcaliati C. Prognostic value of ambulatory blood pressure monitoring. J Hypertens 1995; 13:373-374.
9. Amar J, Bieler L, Salvador M, Chamontin B. Intima media thickness of the carotid artery in white coat and ambulatory hypertension. Arch Mal Coeur Vaiss 1997; 90:1075-1078.
10. Ribeiro L, Gama G, Santos A, Asmar R, Martins L, Polonia J. Arterial distensibility in subjects with white-coat hypertension with and without diabetes or dyslipidaemia: Comparison with normotensives and sustained hypertensives. Blood Press Monit 2000; 5:11-17.
11. Kuwajima I, Suzuki Y, Fujisawa A, Kuramoto K. Is white coat hypertension innocent? Structure and function of the heart in the elderly [see comments]. Hypertension 1993; 22:826-831.
12. Weber MA, Neutel JM, Smith DH, Graettinger WF. Diagnosis of mild hypertension by ambulatory blood pressure monitoring. Circulation 1994; 90:2291-2298.
13. Hernandez del Rey R, Armario P, Sanchez P, Castellsagve J, Pont F, Cardenas G, et al. Frequency of white coat arterial hypertension in mild hypertension. Profile of cardiovascular risk and early organic involvement. Med Clin (Barc) 1996; 106:690-694.
14. Cerasola G, Cottone S, Nardi E, D'Ignoto G, Volpe V, Mule G, et al. White-coat hypertension and cardiovascular risk. J Cardiovasc Risk 1995; 2:545-549.
15. Muscholl MW, Hense HW, Brockel U, Doring A, Riegger GA, Schunkert H. Changes in left ventricular structure and function in patients with white coat hypertension: cross sectional survey. BMJ 1998; 317:565-570.
16. Muldoon MF, Nazzaro P, Sutton-Tyrrell K, Manuck SB. White-coat hypertension and carotid artery atherosclerosis: a matching study. Arch Intern Med 2000; 160:1507-1512.
17. Sega R, Trocino G, Lanzarotti A, Carugo S, Cesana G, Schiavina R, et al. Alterations of cardiac structure in patients with isolated office, ambulatory, or home hypertension: Data from the general population (Pressione Arteriose Monitorate E Loro Associazioni [PAMELA] Study). Circulation 2001; 104:1385-1392.
18. Mallion JM, Baguet JP, Siche JP, Tremel F, De Gaudemaris R. Clinical value of ambulatory blood pressure monitoring. J Hypertens 1999; 17:585-595.
19. Bidlingmeyer I, Burnier M, Bidlingmeyer M, Waeber B, Brunner HR. Isolated office hypertension: a prehypertensive state? J Hypertens 1998; 12:327-332.
20. Saito I, Murata K, Tsujioka M, Kawabe H, Saruta T. Long-term changes in clinic blood pressure in patients with white-coat hypertension. Blood Press Monit 1998; 3:97-100.
21. Polonia JJ, Santos AR, Gama GM, Basto F, Bettencourt PM, Martins LR. Follow-up clinic and ambulatory blood pressure in untreated white-coat hypertensive patients (evaluation after 2-5 years). Blood Press Monit 1997; 2:289-295.
22. White WB, Susser W, McCabe EJ, Mansoor GA. Long-term follow-up of untreated white-coat hypertensive patients. Am J Hypertens 1995; 8:85A.
23. Celis H, Staessen JA, Thijs L, Buntinx F, De Buyzene M, Den Hond E, et al. Cardiovascular risk in white-coat and sustained hypertensive patients. Blood Press 2002; 11:352-356.
24. Kario K, Shimada K, Schwartz JE, Matsuo T, Hoshide S, Pickering TG. Silent and clinically overt stroke in older Japanese subjects with white-coat and sustained hypertension. J Am Coll Cardiol 2001; 38:238-245.
25. Khattar RS, Senior R, Lahiri A. Cardiovascular outcome in white-coat versus sustained mild hypertension: a 10-year follow-up study. Circulation 1998; 98:1892-1897.
26. Gustavsen PH, Hoegholm A, Bang LE, Kristensen KS. White coat hypertension is a cardiovascular risk factor: a 10-year follow-up study. J Hum Hypertens 2003; 17:811-817.
27. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL Jr, et al. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA 2003; 289:2560-2572.
28. 2003 European Society of Hypertension-European Society of Cardiology guidelines for the management of arterial hypertension. J Hypertens 2003; 21:1011-1053.
29. Fagard R, Bielen E, Staessen J, Thijs L, Amery A. Response of ambulatory blood pressure to antihypertensive therapy guided by clinic pressure. Am J Hypertens 1993; 6:648-653.
30. Pickering TG, Levenstein M, Walmsley P. Differential effects of doxazosin on clinic and ambulatory pressure according to age, gender, and presence of white coat hypertension. Results of the HALT Study. Hypertension and Lipid Trial Study Group. Am J Hypertens 1994; 7:848-852.
31. Verdecchia P, Porcellati C, Schillaci G, Borgloni C, Ciucci A, Battistelli M, et al. Ambulatory blood pressure. An independent predictor of prognosis in essential hypertension. Hypertension 1994; 24:793-801.
32. Fagard RH, Staessen JA, Thijs L, Gasowski J, Bulpitt CJ, Clement D, et al. Response to antihypertensive therapy in older patients with sustained and nonsustained systolic hypertension. Systolic Hypertension in Europe (Syst-Eur) Trial Investigators. Circulation 2000; 102:1139-1144.
33. Stergiou GS, Efstathiou SP, Argyraki CK, Roussias LG, Mountokalakis TD. White coat effect in treated versus untreated hypertensive individuals: a case-control study using ambulatory and home blood pressure monitoring. Am J Hypertens 2004; 17:124-128.
34. Verdecchia P, Schillaci G, Borgioni C, et al. Reassessment of definition and prognosis of white-coat-hypertension. Circulation 1996; 94(suppl 1):1340.
35. Mancia G, Sega R, Bravi C, De Vito CJ, Valagussa F, Cesana G, et al. Ambulatory blood pressure normality: results from the PAMELA study. J Hypertens 1995; 13:1377-1390.
36. Staessen JA, Fagard RH, Lijnen PJ, Thijs L, Van Hoof R, Amery AK. Mean and range of the ambulatory pressure in normotensive subjects from a metaanalysis of 23 studies. Am J Cardiol 1991; 67:723-727.
37. White WB. The management and follow-up of patients with white-coat hypertension. Blood Press Monit 1996; 1:S33-S36.
38. Mansoor GA, Abiose A, White WB. Ambulatory blood pressure monitoring; technique and application in the study of cardiac dysfunction and congestive heart failure. Congest Heart Fail 2001; 7:319-324.
39. Pickering TG, James GD. Ambulatory blood pressure and prognosis. J Hypertens Suppl. 1994; 12:S29-S33.
40. Ohkubo T, Imai Y, Tsuji I, Nagai K, Watanabe N, Minami N, et al. Prediction of mortality by ambulatory blood pressure monitoring versus screening blood pressure measurements: a pilot study in Ohasama. J Hypertens 1997; 15:357-364.